drugset / Trial / NCT02543411

Use of Lidocaine in Endoscopic Submucosal Dissection

NCT02543411 ↗

Completed 66 enrolled Severance Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The primary purpose of this study is to investigate the effects of lidocaine on the total administered dose of fentanyl during sedation for endoscopic mucosal resection. The secondary purpose of this study is to investigate the effects of lidocaine on pain score related with endoscopic mucosal resection at time of 30 min, 6 hr, and 24 hr after procedure.

Timeline

Start
2015-09
Primary completion
2015-11
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications